For: |
Zhang Z, Liu ZQ, Zheng PY, Tang FA, Yang PC. Influence of efflux pump inhibitors on the multidrug resistance of |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v16/i10/1279.htm |
Number | Citing Articles |
1 |
Azucena Arévalo, William Alberto Otero, Alba Alicia Trespalacios. Helicobacter pylori: resistencia múltiple en pacientes de Bogotá, Colombia. Biomédica 2019; 39: 125 doi: 10.7705/biomedica.v39i3.4437
|
2 |
Priyanka Ashwath, Akhila Dharnappa Sannejal. The Action of Efflux Pump Genes in Conferring Drug Resistance to Klebsiella Species and Their Inhibition. Journal of Health and Allied Sciences NU 2022; 12(01): 24 doi: 10.1055/s-0041-1731914
|
3 |
Yue Hu, Meng Zhang, Bin Lu, Jinfeng Dai. Helicobacter pylori and Antibiotic Resistance, A Continuing and Intractable Problem. Helicobacter 2016; 21(5): 349 doi: 10.1111/hel.12299
|
4 |
Chao Sun, Jia Huang, Xiaoqian Guo, Chenli Zhang, Li Wei, Ka Ioi Wong, Ziyun Yang, Gang Zhao, Min Lu, Weiyan Yao. An all-in-one therapeutic platform for the treatment of resistant Helicobacter pylori infection. Biomaterials 2024; 308: 122540 doi: 10.1016/j.biomaterials.2024.122540
|
5 |
Jingmei Cai, Tae-Su Kim, Ja Young Jang, Jihyun Kim, Kyungha Shin, Sung-Pyo Lee, Ehn-Kyoung Choi, Sa-Hyun Kim, Min Park, Jong Bae Kim, Yun-Bae Kim. In vitroandin vivoanti-Helicobacter pyloriactivities of FEMY-R7 composed of fucoidan and evening primrose extract. Laboratory Animal Research 2014; 30(1): 28 doi: 10.5625/lar.2014.30.1.28
|
6 |
Amber N. Edinoff, Natalie W. Wu, Katelyn Parker, Edwin Dudossat, Lauren Linquest, Chelsi J. Flanagan, Anam Dharani, Hirni Patel, Olga Willett, Elyse M. Cornett, Adam M. Kaye, Alan D. Kaye. Proton Pump Inhibitors, Kidney Damage, and Mortality: An Updated Narrative Review. Advances in Therapy 2023; 40(6): 2693 doi: 10.1007/s12325-023-02476-3
|
7 |
Mostafa A. Mohammed, Mohammed T. Ahmed, Bahaa E. Anwer, Khaled M. Aboshanab, Mohammad M. Aboulwafa, Monica Cartelle Gestal. Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones. PLOS ONE 2020; 15(8): e0238195 doi: 10.1371/journal.pone.0238195
|
8 |
Bibi Sedigheh Fazly Bazzaz, Mahmoud Fakori, Bahman Khameneh, Hossein Hosseinzadeh. Effects of Omeprazole and Caffeine Alone and in Combination with Gentamicin and Ciprofloxacin Against Antibiotic Resistant Staphylococcus Aureus and Escherichia Coli Strains. Journal of Pharmacopuncture 2019; 22(1): 49 doi: 10.3831/KPI.2019.22.006
|
9 |
Vincenzo De Francesco, Angelo Zullo, Cesare Hassan, Floriana Giorgio, Rosa Rosania, Enzo Ierardi. Mechanisms of <italic>Helicobacter pylori</italic> antibiotic resistance: An updated appraisal. World Journal of Gastrointestinal Pathophysiology 2011; 2(3): 35-41 doi: 10.4291/wjgp.v2.i3.35
|
10 |
Vasudevan Aparna, Kesavan Dineshkumar, Narasumani Mohanalakshmi, Devadasan Velmurugan, Waheeta Hopper, Hendrik W. van Veen. Identification of Natural Compound Inhibitors for Multidrug Efflux Pumps of Escherichia coli and Pseudomonas aeruginosa Using In Silico High-Throughput Virtual Screening and In Vitro Validation. PLoS ONE 2014; 9(7): e101840 doi: 10.1371/journal.pone.0101840
|
11 |
Farideh Siavoshi, Parastoo Saniee, Reza Malekzadeh. Effective antimicrobial activity of rifabutin against multidrug‐resistant Helicobacter pylori. Helicobacter 2018; 23(6) doi: 10.1111/hel.12531
|
12 |
Mei Zhang. High antibiotic resistance rate: A difficult issue for <i>Helicobacter pylori</i> eradication treatment. World Journal of Gastroenterology 2015; 21(48): 13432-13437 doi: 10.3748/wjg.v21.i48.13432
|
13 |
Yan-Qiang Huang, Gan-Rong Huang, Ming-Hui Wu, Hua-Ying Tang, Zan-Song Huang, Xi-Han Zhou, Wen-Qiang Yu, Jian-Wei Su, Xiao-Qiang Mo, Bing-Pu Chen, Li-Juan Zhao, Xiao-Feng Huang, Hong-Yu Wei, Lian-Deng Wei. Inhibitory effects of emodin, baicalin, schizandrin and berberine on <italic>hefA</italic> gene: Treatment of <italic>Helicobacter pylori</italic>-induced multidrug resistance. World Journal of Gastroenterology 2015; 21(14): 4225-4231 doi: 10.3748/wjg.v21.i14.4225
|
14 |
Yi Hu, Yin Zhu, Nong-Hua Lu. Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance. Frontiers in Cellular and Infection Microbiology 2017; 7 doi: 10.3389/fcimb.2017.00168
|
15 |
E. I. Polozova, V. V. Skvortsov, I. E. Trokhina, N. S. Nefedov. Features of the course of gastric ulcer in different age groups. Meditsinskiy sovet = Medical Council 2021; (5): 38 doi: 10.21518/2079-701X-2021-5-38-44
|
16 |
Elżbieta Piątkowska, Jerzy Piątkowski, Anna Przondo-Mordarska. The strongest resistance of Staphylococcus aureus to erythromycin is caused by decreasing uptake of the antibiotic into the cells. Cellular and Molecular Biology Letters 2012; 17(4) doi: 10.2478/s11658-012-0034-3
|
17 |
Xiaoran Ge, Yuying Cai, Zhenghong Chen, Sizhe Gao, Xiwen Geng, Ya Li, Yan Li, Jihui Jia, Yundong Sun.
Bifunctional Enzyme SpoT Is Involved in Biofilm Formation of Helicobacter pylori with Multidrug Resistance by Upregulating Efflux Pump Hp1174 (
gluP
)
. Antimicrobial Agents and Chemotherapy 2018; 62(11) doi: 10.1128/AAC.00957-18
|
18 |
Tae-Su Kim, Kyungha Shin, Joseph H. Jeon, Ehn-Kyoung Choi, Youngjin Choi, Sung-Pyo Lee, Yoon-Bok Lee, Yun-Bae Kim. Comparative analysis of anti-Helicobacter pyloriactivities of FEMY-R7 composed ofLaminaria japonicaandOenothera biennisextracts in mice and humans. Laboratory Animal Research 2015; 31(1): 7 doi: 10.5625/lar.2015.31.1.7
|
19 |
Paweł Krzyżek. Helicobacter pylori Efflux Pumps: A Double-Edged Sword in Antibiotic Resistance and Biofilm Formation. International Journal of Molecular Sciences 2024; 25(22): 12222 doi: 10.3390/ijms252212222
|
20 |
Bruno Squarcio Sanches, Gustavo Miranda Martins, Karine Lima, Bianca Cota, Luciana Dias Moretzsohn, Laercio Tenorio Ribeiro, Helenice P Breyer, Ismael Maguilnik, Aline Bessa Maia, Joffre Rezende-Filho, Ana Carolina Meira, Henrique Pinto, Edson Alves, Ramiro Mascarenhas, Raissa Passos, Julia Duarte de Souza, Osmar Reni Trindade, Luiz Gonzaga Coelho. Detection of <i>Helicobacter pylori</i> resistance to clarithromycin and fluoroquinolones in Brazil: A national survey. World Journal of Gastroenterology 2016; 22(33): 7587-7594 doi: 10.3748/wjg.v22.i33.7587
|
21 |
Lyudmila Boyanova, Galina Gergova, Rumyana Markovska, Nayden Kandilarov, Lyubomir Davidkov, Zoya Spassova, Ivan Mitov. Primary Helicobacter pylori resistance in elderly patients over 20 years: A Bulgarian study. Diagnostic Microbiology and Infectious Disease 2017; 88(3): 264 doi: 10.1016/j.diagmicrobio.2017.05.001
|
22 |
Davide Benedetto Tiz, Danijel Kikelj, Nace Zidar. Overcoming problems of poor drug penetration into bacteria: challenges and strategies for medicinal chemists. Expert Opinion on Drug Discovery 2018; 13(6): 497 doi: 10.1080/17460441.2018.1455660
|
23 |
|
24 |
|
25 |
Lyudmila Boyanova, Lubomir Davidkov, Galina Gergova, Naiden Kandilarov, Ivailo Evstatiev, Emilia Panteleeva, Ivan Mitov. Helicobacter pylori susceptibility to fosfomycin, rifampin, and 5 usual antibiotics for H. pylori eradication. Diagnostic Microbiology and Infectious Disease 2014; 79(3): 358 doi: 10.1016/j.diagmicrobio.2014.03.028
|
26 |
Evariste Tshibangu-Kabamba, Yoshio Yamaoka. Helicobacter pylori infection and antibiotic resistance — from biology to clinical implications. Nature Reviews Gastroenterology & Hepatology 2021; 18(9): 613 doi: 10.1038/s41575-021-00449-x
|
27 |
Vahideh Mohammadzadeh, Tanin Nourollahian, Mohammad Reza Zirak, Seyed Ahmad Emami, Maryam Akaberi. Medicinal and Aromatic Plants. Sustainable Landscape Planning and Natural Resources Management 2024; : 79 doi: 10.1007/978-3-031-64601-0_7
|
28 |
Beatriz Gonçalves Cruz, Thiago Sampaio de Freitas, Maria do Socorro Costa, Ana Raquel Pereira da Silva, Henrique Douglas Melo Coutinho, Selene Maia de Morais, Emmanuel Silva Marinho, Alexandre Magno Rodrigues Teixeira, Hélcio Silva dos Santos. Chemical Composition, Antibacterial and Inhibitory Activity of the Efflux Pump of Essential Oils from Croton piauhiensis Müll.. Nutraceuticals 2023; 3(4): 591 doi: 10.3390/nutraceuticals3040042
|
29 |
Sun Min Lee, Nayoung Kim, Yong Hwan Kwon, Ryoung Hee Nam, Jung Mogg Kim, Jong Youn Park, Yeon Suk Lee, Dong Ho Lee. rdxA, frxA, and efflux pump in metronidazole‐resistant Helicobacter pylori: Their relation to clinical outcomes. Journal of Gastroenterology and Hepatology 2018; 33(3): 681 doi: 10.1111/jgh.13906
|
30 |
Divya S. Raj, Dinesh Kumar Kesavan, Natarajan Muthusamy, S. Umamaheswari. Efflux pumps potential drug targets to circumvent drug Resistance – Multi drug efflux pumps of Helicobacter pylori. Materials Today: Proceedings 2021; 45: 2976 doi: 10.1016/j.matpr.2020.11.955
|
31 |
Suvithan Rajadurai, Jonathan J. C. Ho, Erick A. Argueta, Yousef Elfanagely, Steven F. Moss. When and How Should Resistance Testing Be Performed to Improve H. pylori Eradication?. Current Treatment Options in Gastroenterology 2023; 21(4): 447 doi: 10.1007/s11938-023-00436-y
|
32 |
Zeling Xu, Aixin Yan. Multidrug Efflux Systems in Microaerobic and Anaerobic Bacteria. Antibiotics 2015; 4(3): 379 doi: 10.3390/antibiotics4030379
|
33 |
Gerardo Zerbetto De Palma, Nicolas Mendiondo, Andrés Wonaga, Luis Viola, Daniela Ibarra, Esteban Campitelli, Nicolas Salim, Rodolfo Corti, Cinthia Goldman, Mariana Catalano. Occurrence of Mutations in the Antimicrobial Target Genes Related to Levofloxacin, Clarithromycin, and Amoxicillin Resistance inHelicobacter pyloriIsolates from Buenos Aires City. Microbial Drug Resistance 2017; 23(3): 351 doi: 10.1089/mdr.2015.0361
|
34 |
Nabeela Farhat, Abid Ali, Robert A. Bonomo, Asad U. Khan. Efflux pumps as interventions to control infection caused by drug-resistance bacteria. Drug Discovery Today 2020; 25(12): 2307 doi: 10.1016/j.drudis.2020.09.028
|
35 |
Porjai Rattanapanadda, Hung-Chih Kuo, Ming-Kun Hsieh, Chi-Chung Chou. EFFECT OF EFFLUX PUMP INHIBITORS ON ANTIMICROBIAL ACTIVITY OF FLORFENICOL AGAINST RESISTANT STRAINS OF PORCINE ACTINOBACILLUS PLEUROPNEUMONIAE AND PASTEURELLA MULTOCIDA. Taiwan Veterinary Journal 2020; 46(04): 151 doi: 10.1142/S1682648520500146
|
36 |
Judit Alarcón-Millán, Gloria Fernández-Tilapa, Enoc Mariano Cortés-Malagón, Carlos Alberto Castañón-Sánchez, José De Sampedro-Reyes, Iván Cruz-del Carmen, Reyes Betancourt-Linares, Adolfo Román-Román. Clarithromycin resistance and prevalence of Helicobacter pylori virulent genotypes in patients from Southern México with chronic gastritis. Infection, Genetics and Evolution 2016; 44: 190 doi: 10.1016/j.meegid.2016.06.044
|
37 |
Jody Andersen, Gui-Xin He, Prathusha Kakarla, Ranjana KC, Sanath Kumar, Wazir Lakra, Mun Mukherjee, Indrika Ranaweera, Ugina Shrestha, Thuy Tran, Manuel Varela. Multidrug Efflux Pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus Bacterial Food Pathogens. International Journal of Environmental Research and Public Health 2015; 12(2): 1487 doi: 10.3390/ijerph120201487
|
38 |
Zeeshan Umar, Jia-Wei Tang, Barry J. Marshall, Alfred Chin Yen Tay, Liang Wang.
Rapid diagnosis and precision treatment of
Helicobacter pylori
infection in clinical settings
. Critical Reviews in Microbiology 2024; : 1 doi: 10.1080/1040841X.2024.2364194
|
39 |
Dongsun Park, Kyungha Shin, Youngjin Choi, Haiyu Guo, Yeseul Cha, Sa-Hyun Kim, Nam Soo Han, Seong Soo Joo, Jae Kwon Choi, Yoon Bok Lee, Ehn-Kyoung Choi, Jong Bae Kim, Yun-Bae Kim. Antimicrobial activities of ethanol and butanol fractions of white rose petal extract. Regulatory Toxicology and Pharmacology 2016; 76: 57 doi: 10.1016/j.yrtph.2016.01.011
|
40 |
Vaneet Jearth, Manas Kumar Panigrahi. Current paradigms in the management of refractory Helicobacter pylori infection. Indian Journal of Gastroenterology 2023; 42(6): 766 doi: 10.1007/s12664-023-01448-3
|
41 |
Jung Won Lee, Nayoung Kim, Jung Mogg Kim, Ryoung Hee Nam, Hyun Chang, Jae Yeon Kim, Cheol Min Shin, Young Soo Park, Dong Ho Lee, Hyun Chae Jung. Prevalence of Primary and Secondary Antimicrobial Resistance of Helicobacter pylori in Korea from 2003 through 2012. Helicobacter 2013; 18(3): 206 doi: 10.1111/hel.12031
|
42 |
Sandra Salillas, Juan José Galano-Frutos, Alejandro Mahía, Ritwik Maity, María Conde-Giménez, Ernesto Anoz-Carbonell, Helena Berlamont, Adrian Velazquez-Campoy, Eliette Touati, Uwe Mamat, Ulrich E. Schaible, José A. Gálvez, María D. Díaz-de-Villegas, Freddy Haesebrouck, José A. Aínsa, Javier Sancho. Selective Targeting of Human and Animal Pathogens of the Helicobacter Genus by Flavodoxin Inhibitors: Efficacy, Synergy, Resistance and Mechanistic Studies. International Journal of Molecular Sciences 2021; 22(18): 10137 doi: 10.3390/ijms221810137
|
43 |
|
44 |
Md Hasanuzzaman, Chang Seok Bang, Eun Jeong Gong. Antibiotic Resistance of Helicobacter pylori: Mechanisms and Clinical Implications. Journal of Korean Medical Science 2024; 39(4) doi: 10.3346/jkms.2024.39.e44
|
45 |
Jung Won Lee, Nayoung Kim, Ryoung Hee Nam, Ji Hyun Park, Yoon Jin Choi, Jung Mogg Kim, Joo Sung Kim, Hyun Chae Jung. GenoType HelicoDR test in the determination of antimicrobial resistance ofHelicobacter pyloriin Korea. Scandinavian Journal of Gastroenterology 2014; 49(9): 1058 doi: 10.3109/00365521.2014.894117
|
46 |
György Miklós Buzás. Helicobacter pylori – 2010. Orvosi Hetilap 2010; 151(49): 2003 doi: 10.1556/oh.2010.28982
|
47 |
Fansen Meng, Hongjin Tao, Yan Mi, Tianyu Yang, Xuanping Wang, Yuyo Go, Yunjuan Lin, Gangshi Wang. Nanocluster-mediated photothermia improves eradication efficiency and antibiotic sensitivity of Helicobacter pylori. Cancer Nanotechnology 2022; 13(1) doi: 10.1186/s12645-022-00121-2
|
48 |
E. David G. McIntosh. Antibiotic Resistance. Handbook of Experimental Pharmacology 2012; 211: 153 doi: 10.1007/978-3-642-28951-4_10
|
49 |
Marwa S. Fathi, Runia Fouad EL-Folly, Rania Ahmed Hassan, Mohammed Ezz El-Arab. Genotypic and phenotypic patterns of antimicrobial susceptibility of Helicobacter pylori strains among Egyptian patients. Egyptian Journal of Medical Human Genetics 2013; 14(3): 235 doi: 10.1016/j.ejmhg.2013.03.004
|
50 |
Yifan Lin, Yongfu Shao, Jianing Yan, Guoliang Ye. Antibiotic resistance in Helicobacter pylori: From potential biomolecular mechanisms to clinical practice. Journal of Clinical Laboratory Analysis 2023; 37(7) doi: 10.1002/jcla.24885
|
51 |
V. Yu. Rusyaev, D. A. Sheptulin, N. V. Shulpekova, Yu. O. Shulpekova. Rabeprazole in the treatment of duodenal ulcer desease and functional dyspepsia. Medical Council 2018; (12): 70 doi: 10.21518/2079-701X-2018-12-70-76
|
52 |
Bahareh Attaran, Tahereh Falsafi, Nassim Ghorbanmehr. Effect of biofilm formation by clinical isolates of <i>Helicobacter pylori</i> on the efflux-mediated resistance to commonly used antibiotics. World Journal of Gastroenterology 2017; 23(7): 1163-1170 doi: 10.3748/wjg.v23.i7.1163
|
53 |
L. G. Vologzanina, O. A. Igumnova, I. V. Petuhova. Effectiveness of eradication therapy for Hp infection of residents of Perm and the Perm region. Experimental and Clinical Gastroenterology 2023; (6): 14 doi: 10.31146/1682-8658-ecg-214-6-14-21
|
54 |
Paweł Krzyżek, Roman Franiczek, Barbara Krzyżanowska, Łukasz Łaczmański, Paweł Migdał, Grażyna Gościniak. In Vitro Activity of Sertraline, an Antidepressant, Against Antibiotic-Susceptible and Antibiotic-Resistant Helicobacter pylori Strains. Pathogens 2019; 8(4): 228 doi: 10.3390/pathogens8040228
|
55 |
Xiaofen Jia, Qiuyue Huang, Miaomiao Lin, Yingming Chu, Zongming Shi, Xuezhi Zhang, Hui Ye. Revealing the novel effect of Jinghua Weikang capsule against the antibiotic resistance of Helicobacter pylori. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.962354
|
56 |
Ya-fei LI, Hong-xia JIANG, Rong XIANG, Na SUN, Ya-nan ZHANG, Li-qing ZHAO, Peng GU, Li-qiao WANG, Zhen-ling ZENG. Effects of two efflux pump inhibitors on the drug susceptibility of Riemerella anatipestifer isolates from China. Journal of Integrative Agriculture 2016; 15(4): 929 doi: 10.1016/S2095-3119(15)61031-0
|
57 |
Xiaoling Gong, Youhua Wang, Ying An, Zhen Li, Dongsheng Liu, Xie Yong.
The crosstalk between efflux pump and resistance gene mutation in
Helicobacter pylori
. Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2379439
|
58 |
D N Andreev, D T Dicheva, I V Maev. Possibilities for optimization of eradication therapy for Helicobacter pylori infection in modern clinical practice. Terapevticheskii arkhiv 2017; 89(2): 84 doi: 10.17116/terarkh201789284-90
|
59 |
Theodore Rokkas, Konstantinos Ekmektzoglou.
Advances in the pharmacological and regulatory management of multidrug resistant
Helicobacter pylori
. Expert Review of Clinical Pharmacology 2023; 16(12): 1229 doi: 10.1080/17512433.2023.2282061
|
60 |
Tae-Su Kim, Ehn-Kyoung Choi, Jihyun Kim, Kyungha Shin, Sung-Pyo Lee, Youngjin Choi, Joseph H. Jeon, Yun-Bae Kim. Anti-Helicobacter pyloriactivities of FEMY-R7 composed of fucoidan and evening primrose extract in mice and humans. Laboratory Animal Research 2014; 30(3): 131 doi: 10.5625/lar.2014.30.3.131
|
61 |
Yun-Hui Yang, Dongsun Park, Goeun Yang, Sun Hee Lee, Dae Kwon Bae, Jangbeen Kyung, Dajeong Kim, Ehn-Kyoung Choi, Jae-Cheol Son, Seock-Yeon Hwang, Yun-Bae Kim. Anti-Helicobacter pylorieffects of IgY from egg york of immunized hens. Laboratory Animal Research 2012; 28(1): 55 doi: 10.5625/lar.2012.28.1.55
|
62 |
Jennifer Li, Xian-Zhi Li. Efflux-Mediated Antimicrobial Resistance in Bacteria. 2016; : 489 doi: 10.1007/978-3-319-39658-3_19
|
63 |
I. G. Pakhomova. Modern opportunities to improve the effectiveness of eradication therapy on a clinical case. Meditsinskiy sovet = Medical Council 2022; (15): 28 doi: 10.21518/2079-701X-2022-16-15-28-34
|
64 |
|
65 |
Jung Won Lee, Nayoung Kim, Ryoung Hee Nam, Jung Mogg Kim, Jong Youn Park, Sun Min Lee, Joo Sung Kim, Dong Ho Lee, Hyun Chae Jung. High Efficacy of Finafloxacin on Helicobacter pylori Isolates at pH 5.0 Compared with That of Other Fluoroquinolones. Antimicrobial Agents and Chemotherapy 2015; 59(12): 7629 doi: 10.1128/AAC.01467-15
|
66 |
Brian White, Maria Winte, Joshua DeSipio, Sangita Phadtare. Clinical Factors Implicated in Antibiotic Resistance in Helicobacter pylori Patients. Microorganisms 2022; 10(2): 322 doi: 10.3390/microorganisms10020322
|
67 |
Gihong Park, Bokyung Kim, Hyunsoo Chung, Sang Gyun Kim, Soo-Jeong Cho. Types of 23S Ribosomal RNA Point Mutations Affecting Helicobacter pylori Eradication Rates in Clarithromycin-Based Triple Therapy. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2023; 23(4): 268 doi: 10.7704/kjhugr.2023.0037
|
68 |
Ying Li, Zhixin Huang, Yanyan Shang, Xinqiang Xie, Runshi Yang, Huizhen Chen, Zhi Wang, Liang Xue, Rui Pang, Jumei Zhang, Yu Ding, Moutong Chen, Juan Wang, Jianhui Chen, Qingping Wu. Exploration of the molecular mechanisms underlying the antibiotic resistance of Helicobacter pylori: A whole‐genome sequencing‐based study in Southern China. Helicobacter 2022; 27(2) doi: 10.1111/hel.12879
|
69 |
Tahereh Falsafi, Azadeh Ehsani, Bahareh Attaran, Vahid Niknam. Association of hp1181 and hp1184 Genes With the Active Efflux Phenotype in Multidrug-Resistant Isolates of Helicobacter pylori. Jundishapur Journal of Microbiology 2016; 9(4) doi: 10.5812/jjm.30726
|
70 |
O. D. Lopina, B. K. Nurgalieva, T. L. Lapina. Current Trends in Treatment for Acid-Dependent Diseases: Clinical Efficacy and Safety of Rabeprazole. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2021; 31(4): 55 doi: 10.22416/1382-4376-2021-31-4-55-63
|
71 |
Bahgat Fayed, Jayalakshmi Jagal, Roberta Cagliani, Reena A. Kedia, Amr Elsherbeny, Hulya Bayraktutan, Ghalia Khoder, Mohamed Haider. Co-administration of amoxicillin-loaded chitosan nanoparticles and inulin: A novel strategy for mitigating antibiotic resistance and preserving microbiota balance in Helicobacter pylori treatment. International Journal of Biological Macromolecules 2023; 253: 126706 doi: 10.1016/j.ijbiomac.2023.126706
|
72 |
Laura R. Marks, Emily A. Clementi, Anders P. Hakansson, Herminia de Lencastre. Sensitization of Staphylococcus aureus to Methicillin and Other Antibiotics In Vitro and In Vivo in the Presence of HAMLET. PLoS ONE 2013; 8(5): e63158 doi: 10.1371/journal.pone.0063158
|
73 |
Li-Yuan Yu, Lu-Ning Sun, Xue-Hui Zhang, Yue-Qi Li, Lei Yu, Zi-Qing-Yun Yuan, Ling Meng, Hong-Wen Zhang, Yong-Qing Wang. A Review of the Novel Application and Potential Adverse Effects of Proton Pump Inhibitors. Advances in Therapy 2017; 34(5): 1070 doi: 10.1007/s12325-017-0532-9
|
74 |
David C. P. Chen. The Use of IgY (Immunoglobulin Yolk) in Cancer Prevention Seen in Liver and Stomach Cancers. 2021 IEEE 3rd Eurasia Conference on Biomedical Engineering, Healthcare and Sustainability (ECBIOS) 2021; : 71 doi: 10.1109/ECBIOS51820.2021.9510511
|